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Abstract
Background:  Magnetocardiography enables the precise determination of fetal cardiac time
intervals (CTI) as early as the second trimester of pregnancy. It has been shown that fetal CTI
change in course of gestation. The aim of this work was to investigate the dependency of fetal CTI
on gestational age, gender and postnatal biometric data in a substantial sample of subjects during
normal pregnancy.
Methods: A total of 230 fetal magnetocardiograms were obtained in 47 healthy fetuses between
the 15th and 42nd week of gestation. In each recording, after subtraction of the maternal cardiac
artifact and the identification of fetal beats, fetal PQRST courses were signal averaged. On the basis
of therein detected wave onsets and ends, the following CTI were determined: P wave, PR interval,
PQ interval, QRS complex, ST segment, T wave, QT and QTc interval. Using regression analysis,
the dependency of the CTI were examined with respect to gestational age, gender and postnatal
biometric data.
Results: Atrioventricular conduction and ventricular depolarization times could be determined
dependably whereas the T wave was often difficult to detect. Linear and nonlinear regression
analysis established strong dependency on age for the P wave and QRS complex (r2 = 0.67, p <
0.001 and r2 = 0.66, p < 0.001) as well as an identifiable trend for the PR and PQ intervals (r2 = 0.21,
p < 0.001 and r2 = 0.13, p < 0.001). Gender differences were found only for the QRS complex from
the 31st week onward (p < 0.05). The influence on the P wave or QRS complex of biometric data,
collected in a subgroup in whom recordings were available within 1 week of birth, did not display
statistical significance.
Conclusion: We conclude that 1) from approximately the 18th week to term, fetal CTI which
quantify depolarization times can be reliably determined using magnetocardiography, 2) the P wave
and QRS complex duration show a high dependency on age which to a large part reflects fetal
growth and 3) fetal gender plays a role in QRS complex duration in the third trimester. Fetal
development is thus in part reflected in the CTI and may be useful in the identification of
intrauterine growth retardation.
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Background
In recent years it has been shown that fetal magnetocardi-
ography (FMCG) is suited for the determination of fetal
cardiac time intervals (CTI) [1-7]. Various intervals reflect-
ing atrial and ventricular de- and repolarization times
have been identified on the basis of the waveforms of the
P wave, the PR interval, the QRS complex, the T wave and
others. These studies all examine the QRS complex and
most present the P wave or PR interval but none report on
all relevant CTI. The durations of the individual CTI stud-
ied tend to cover a wide range of values. In particular with
respect to the P wave and QRS complex, one of the pri-
mary reasons for this is the dependency on the gestational
age of the fetus. This is presumed to be associated with the
increase in cardiac tissue mass and dimensions concomi-
tant with fetal growth [8]. Also, it has been shown that the
QRS complex may be influenced by the gender of the fetus
[9]. Other CTI, such as those involving the T wave, display
a high degree of variance because the onset and end of this
wave can often not be determined unambiguously due to
its low amplitude, low frequency nature.
Furthermore, it has been shown that there are systematic
differences in CTI duration between the various groups
active in this field [8]. One must thus presume that the
equipment and procedures used in data acquisition and
evaluation play a role in contributing to the distribution
of the data. In previous work, we have examined factors
such as biomagnetometer sensor configuration and
observer reproducibility and have been able to show that
the number of registration channels and signal-to-noise
characteristics affect reliability in the determination of the
CTI [10]. The same work showed, on the other hand, that
inter-observer reproducibility was high when appropriate
criteria in the determination of waveform boundaries
were maintained. On the whole, there is consensus
between most investigators that, in order to produce com-
parable results, certain guidelines should be followed in
data acquisition, evaluation and documentation [11].
Various possibilities for the clinical application of FMCG
have been proposed. With respect to CTI it has been sug-
gested that their utility may lie in the identification of
fetuses with arrhythmias [12-14], congenital heart defects
[15,16] and intrauterine growth retardation (IUGR)
[4,17]. With IUGR in particular, the expectation is that, all
other things being equal, the duration of the CTI will be
shorter in compromised fetuses. Thus, in order to opti-
mize the potential discriminatory power of the CTI, perti-
nent factors, not associated with disease states, which may
influence CTI duration must be identified and their effect
estimated. The aim of this work was to precisely deter-
mine all relevant CTI in a relatively large group of healthy
fetuses and to investigate the effect of gestational age and
gender using regression analysis. The results might serve
as reference values for future work dealing with patholog-
ical fetal conditions. Furthermore, a preliminary attempt
to associate CTI duration with postnatal biometric data
was undertaken.
Methods
The subjects in this study included 43 women in 47
healthy pregnancies (32 ± 3 years of age) in which fetal
gender was documented. Subjects excluded from this
study were those in whom the fetuses exhibited arrhyth-
mic beats [13], IUGR, congenital heart disease or in which
maternal hypertension, diabetes or nicotine abuse was
present. Of the included subjects, 20 were para 0, 23 para
I and 4 para II. Twenty-eight (60%) of the fetuses were
male, 19 (40%) were female. We recorded 255 FMCGs
between the 12th and 42nd week of gestation, of which 230
displayed sufficient signal quality to enable evaluation.
All of the 25 recordings which could not be evaluated
were prior to the 20th week, the success rates between the
12th and 19th week being 0%, 0%, 0%, 17%, 29%, 17%,
80% and 90% (Fig. 1). Of the remaining 230 available
FMCGs between the 15th and 42nd week of gestation, we
obtained on average 4.9 ± 4.3 per fetus (range 1–23). In
the period from the 18th to the 39th week, the number of
recordings per week of gestation lay between 6 and 14
(10.0 ± 2.3), before the 18th and after the 39th week the
number of recordings was between one and three per
week of gestation (Fig. 1). Of all evaluated recordings, 116
(50.4%) were performed in male fetuses, 114 (49.6%) in
female. The study is in compliance with the Helsinki Dec-
laration, was approved by the local ethics committee and
all mothers gave written informed consent.
Data acquisition
FMCGs were acquired using a 61 channel biomagnetom-
eter (Magnes 1300C, 4D Neuroimaging, San Diego) in
162 cases. The sensing channels are arranged as 4 concen-
tric rings around a central channel with an overall diame-
ter of 32.4 cm and an area of coverage of ca. 800 cm2. A
configuration of 11 reference coils is used to detect ambi-
ent noise and intrinsic system noise is given as being less
than 10 fT/Hz1/2 (fT: femtotesla) for frequencies > 5 Hz. A
further 68 FMCGs were recorded using a 37 channel sys-
tem (Krenikon, Siemens, Erlangen). This system consists
of sensing coils configured as 1st order gradiometers
(baseline 7 cm) in a hexagonal grid with an overall diam-
eter of 19 cm (area of coverage: ca. 283 cm2). System noise
is given as less than 30 fT/Hz1/2 for frequencies > 2 Hz and
10 fT/Hz1/2 for frequencies > 10 Hz. Previous work has
shown that the estimation of CTI is comparable for these
two systems [10]. For data acquisition the mothers were in
a supine position with the biomagnetometer placed as
close to the abdomen as possible while avoiding skin con-
tact. The 61 channel system was positioned symmetrically
over the abdomen, the lower rim over the pubis and theBMC Pregnancy and Childbirth 2004, 4 http://www.biomedcentral.com/1471-2393/4/6
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upper rim approximately over the xyphoid. The smaller
37 channel system was positioned such that channels at
the center of the sensor displayed high amplitude fetal
QRS complexes. Data were usually recorded for 5 minutes
at a sampling rate of 1 kHz and with a bandpass of 1–200
Hz. To reduce the effects of external noise, all measure-
ments were performed in a standard shielded room
(AK3b, Vacuumschmelze, Hanau). Recordings were gen-
erally performed between 10 AM and 4 PM.
Data analysis
In each set of data, maternal heart beats were identified by
correlation to a maternal QRS signal template and the
maternal PQRST signal components were then digitally
averaged and subsequently subtracted from the signal
traces. In the resulting traces, fetal beats were similarly
identified on the basis of a representative fetal QRS signal
template. Fetal PQRST courses to be averaged were chosen
on the basis of a good correlation (r ≥ 0.90) to the tem-
plate (generally»300 beats). In the averaged data, the
onsets (or endpoints) of the P wave, QRS complex and T
wave were defined as the visually identifiable first (or last)
deviation from the signal's baseline in any one channel
out of all channels available for evaluation [11]. Due to
the low amplitude of the T wave and possible DC drift, its
onsets and end were determined on the basis of identifia-
ble changes in amplitude at appropriate latencies. All
channels were displayed individually avoiding overlap
and within a fixed time window (20 ms/cm) and a
defined range of amplitudes (0.1–0.5 pT/cm for the P and
Number of recordings Figure 1
Number of recordings Number of FMCG recordings obtained between the 12th and 42nd week of gestation. Viable record-
ings were available as early as the 15th week and, from the 20th week on, all recordings could be evaluated (no signal = signal-to-
noise ratio too low for the identification of fetal QRS complexes; signal = sufficient signal quality for evaluation).BMC Pregnancy and Childbirth 2004, 4 http://www.biomedcentral.com/1471-2393/4/6
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T wave, 0.5–1.0 pT/cm for the QRS complex). The onsets
and ends were independently determined by two
experienced investigators and their results were com-
pared. The final value for each time point was set accord-
ingly: in cases of differences > 2 ms both investigators re-
evaluated and corrected the results, otherwise the results
were averaged. These time points were then used to calcu-
late the duration of the CTI. We determined the consecu-
tive, non-overlapping (disjunct) intervals as follows: P
wave = Pend - Ponset, PQ interval = QRSonset - Pend, QRS com-
plex = QRSend - QRSonset, ST segment = Tonset - QRSend and
T wave = Tend - Tonset. Furthermore, the following compos-
ite CTI were determined: PR interval = P wave + PQ inter-
val and QT interval = QRS complex + ST segment + T wave
(see Figure 2). Also, the rate corrected QT interval (QTc)
was calculated according to Bazett's formula [18]. In some
traces, signal quality did not permit the unequivocal iden-
tification of the timing of an event and the corresponding
CTI were not determined.
The dependency on gestational age was assessed for the
CTI over all data sets using regression analysis. The same
dependency in the male and female subgroups was simi-
larly examined and compared. In order to examine the
relationship between postnatal biometric data (birth
weight, head circumference and crown-heel length) and
the CTI, we examined the dependency of those intervals
which clearly correlated to development. For this, only
data sets in which the CTI were determined within the last
7 prepartum days were considered.
Statistics
Values describing the subject and FMCG acquisition
groups were expressed as means ± standard deviation.
Simple linear as well as nonlinear regression was used to
estimate the parameters governing the change of the CTI
over gestational age. For all regressions, the dependencies
due to repeated measurements were considered by per-
forming a robust regression using a modified Huber/
White/Sandwich estimator of variance [19]. For any inter-
val, the model that demonstrated the best fit, based on the
coefficient of determination, was chosen as most appro-
priate. For those intervals displaying a clear dependency
on gestational age with respect to the best fitting model,
estimated values and 90% prediction intervals were calcu-
lated on a weekly basis. For those intervals lacking a clear
dependency, measures of location were calculated overall.
To examine the differences between male and female CTI
at a specific week of gestation, all values of each gender
were projected to that week on the basis of each sex's best
fitting model and the projected group values compared
using Mann-Whitney U test. The dependency of the CTI
on biometric parameters was examined using simple lin-
ear regression. Statistical significance was assumed at a
level of 0.05.
Results
Unambiguous identification of the waveform onsets and
offsets was possible in virtually all of the fetal atrial and
ventricular depolarization signals, with 99% of the P wave
and PQ interval durations as well as 100% of the QRS
complex durations available for evaluation. The onsets
and ends of ventricular repolarization were markedly
more difficult to identify. The determination rates of 94%
for the T wave and the ST segment durations were
achieved only by meticulous examination of the wave-
forms [10]. It follows that the results must be viewed with
caution as the low amplitude, low frequency character of
the T wave involved a higher risk of error.
Averaged FMCG signal Figure 2
Averaged FMCG signal FMCG signal traces from 4 
selected channels of the averaged data of a recording per-
formed in the 39th week of gestation. The vertical lines show 
how the signal onsets and ends were set and used to deter-
mine the cardiac time intervals. (B = magnetic field strength)BMC Pregnancy and Childbirth 2004, 4 http://www.biomedcentral.com/1471-2393/4/6
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Gestational age
The CTI showed varying dependency on gestational age:
Figure 3 shows that, of the contiguous, disjunct intervals,
in particular the duration of the P wave and QRS complex
increased clearly over time whereas the PQ interval
showed a slight tendency to decrease with age. The ST seg-
ment and T wave duration demonstrated a wide spread
without a clear trend. The composite intervals were char-
acterized by a modest positive relationship to week of ges-
tation, primarily reflecting the influence of the
depolarization times. Regression analysis confirmed the
visual impression (Table 1) with statistically significant
slopes for all intervals except the ST segment and the T
wave. The model fits were especially good for the P wave
and the QRS complex. Implementing non-linear models
improved the fit for the PQ and PR interval as well as the
QRS complex.
For the intervals showing the clearest changes over time (P
wave and QRS complex) we calculated various measures
of location on the basis of the best fitting models for each
gestational week from the 17th to the 42nd (see Table 2,
Table 3). Although the dependency on age was not as pro-
nounced, we did the same for the PR and PQ intervals
(Table 2). For the remaining intervals, the scatter of the
data was too large to permit a meaningful differentiation
according to week of gestation (see Fig. 3) and the numer-
ical description of the data is given without reference to
gestational age (Table 4).
Gender
With respect to fetal gender, most intervals showed no
obvious differences in duration (Figure 3). However, the
duration of the QRS complex seemed to be shorter in the
females, particularly after the 30th week of gestation. As
this suggested a different development between the two
sexes, we examined the dependency on age separately for
these subgroups using different models. We found that
the best fitting model for the males was logarithmic
(ln(QRS) = 0.594*ln(week) + 1.852, r2 = 0.64, p < 0.001)
and hyperbolic for females (QRS = -646*(1/week)+68, r2
= 0.71, p < 0.001). Using these respective models to adjust
for different weeks of gestation showed that QRS duration
differed significantly between gender from the 31st week
onward. We thus used these model to calculate values for
the QRS complex separately for male and female subjects
(Table 3).
Biometric data
As the P wave and QRS complex showed a distinct rela-
tionship to gestational age reflecting fetal growth, we
assumed that an association to postpartum biometric
parameters might exist. We therefore examined the dura-
tion of these two intervals with respect to birth weight,
head circumference and crown-heel length in those
fetuses in whom MCG recording were obtained within 7
days of parturition. None of the intervals showed a statis-
tically significant relationship to the biometric data (Table
5). However a trend was apparent for head circumference,
especially with respect to the QRS complex.
Discussion
The main findings of this study are that, of the time inter-
vals that compose fetal cardiac electrophysiological activ-
ity, atrial and ventricular depolarization times clearly
increase in the second and third trimester of pregnancy
and that these changes are in part dependent on gender.
Furthermore, ventricular repolarization duration and
intervals not involving depolarization do not demon-
strate these dependencies.
Our results are in general agreement with those in Stinstra
et al [8] which included a large amount of data
contributed by a number of laboratories. However that
study had the difficulty that the data showed systematic
differences between the data of the contributing centers.
There may be various reasons for this bias resulting from
different recording and evaluation techniques [10]. The
work presented here largely avoids these technical diffi-
culties and we may thus expect the observed trends and
variance to reflect more closely the physiological factors
involved.
A further difficulty in comparing the published results of
different groups is that the documentation of the changes
during pregnancy takes on various forms. The reports may
include mean and extreme values averaged over ≥ 4 week
periods [1,3,5-7] or regression-based estimated values
[8,17,20]. The data may be plotted with or without confi-
dence intervals [4-8,17,20]. In some of the work, estima-
tions of age dependency are given, based on correlation
and/or regression analysis [1,4-8,17,20]. In this report we
have given most of this information on all CTI we exam-
ined and we have included a week by week descriptive
analysis for those CTI displaying a distinct dependency on
age, namely the P wave, PR and PQ interval as well as the
QRS complex. Considering the size of the study popula-
tion and the relatively consistent recording and evaluation
procedures applied in accordance with accepted standards
[11], these values may serve as reference values.
We did not consider it appropriate to take the effect of ges-
tational age into account for the QT and QTc intervals
although they showed a statistically significant slope in
the regression analysis. These intervals, as well as the ST
segment and T wave, were characterized by low
coefficients of determination (< 0.08), indicating that the
effect of age was minimal with a wide spread of data at any
specific gestational age and a large data overlap overBMC Pregnancy and Childbirth 2004, 4 http://www.biomedcentral.com/1471-2393/4/6
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extended gestational periods. Thus a realistic estimation
of their duration can be made independently of age.
The distinct relationship between depolarization times
and age has often been posited to reflect changes in heart
size over gestation [e.g. [8]]: the larger the cardiac cham-
bers, the more time needed for the depolarization wave to
travel over the myocardium. Indeed, mammalian hearts
display a dependency on body mass with respect to organ
size and conduction time [21]. The weight of the fetal
Scatter plots of fetal CTI vs. gestational age Figure 3
Scatter plots of fetal CTI vs. gestational age Duration of CTI with respect to gestational age: disjunct intervals (P wave, 
PQ interval, QRS complex, ST segment, T wave) in the top two rows, composite intervals (PR, QT and QTc interval) in the 
bottom row (males , females +).BMC Pregnancy and Childbirth 2004, 4 http://www.biomedcentral.com/1471-2393/4/6
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Table 1: CTI dependency on gestational age. Dependency of fetal cardiac time intervals on gestational age (in weeks): coefficients of 
determination (r2), y-intercepts, slopes and the p-value of the slopes (values < .05 in bold type). Linear regression parameters are given 
for each disjunct interval (upper rows) and each composite interval (lower rows). Non-linear regression parameters are also given for 
those intervals in which an improved model fit was found (quadratic: PQ and PR interval, double logarithmic: QRS complex).
regression 
type
N r2 y-intercept 
(ms)
slope (ms/week) p slope (ms/week2) p
P wave linear 228 0.67 14.0 1.37 <0.001
PQ interval linear 228 0.07 67.7 -0.49 <0.001
PQ interval non-linear 228 0.13 14.2 3.38 0.021 -0.07 0.008
QRS complex linear 230 0.62 19.3 0.92 <0.001
ln (QRS) non-linear 230 0.66 1.8 0.60* <0.001
ST segment linear 217 0.01 60.4 0.32 0.169
T wave linear 216 0.00 126.0 0.00 1.000
PR interval linear 228 0.16 81.7 0.88 <0.001
PR interval non-linear 228 0.21 20.0 5.35 <0.001 -0.08 0.002
QT interval linear 216 0.07 205.8 1.24 <0.001
QTc interval linear 216 0.06 326.6 1.65 <0.001
* the slope in this regression equation is ms/ln(week)
Table 2: Weekly values for P, PQ and PR Estimated value for the P wave, PQ interval and PR interval and their respective 90% prediction 
interval (PI) based on each interval's best fitting regression model. Values from the 17th to the 42nd week are given. N is the number of 
case avaliable for the model in any respective week.
Gestational age week N P wave (ms) estimated value 
(90% PI)
PQ interval (ms) estimated 
value (90% PI)
PR interval (ms) estimated 
value (90% PI)
17 1 37 (27 – 48) 52 (34 – 71) 89 (67 – 110)
18 5 39 (28 – 49) 54 (35 – 72) 91 (70 – 113)
19 8 40 (30 – 50) 54 (36 – 73) 94 (73 – 115)
20 9 41 (31 – 52) 55 (37 – 74) 96 (75 – 117)
21 8 43 (32 – 53) 56 (38 – 74) 98 (77 – 119)
22 9 44 (34 – 55) 56 (38 – 75) 100 (80 – 121)
23 12 45 (35 – 56) 57 (39 – 75) 102 (81 – 123)
24 10 47 (36 – 57) 57 (39 – 75) 104 (83 – 125)
25 9 48 (38 – 59) 57 (39 – 75) 106 (85 – 127)
26 8 50 (39 – 60) 57 (39 – 75) 107 (86 – 128)
27 11 51 (41 – 61) 57 (39 – 75) 108 (88 – 129)
28 16 52 (42 – 63) 57 (38 – 75) 110 (89 – 130)
29 11 54 (43 – 64) 56 (38 – 75) 111 (90 – 131)
30 12 55 (45 – 65) 56 (38 – 74) 111 (90 – 132)
31 7 56 (46 – 67) 55 (37 – 73) 112 (91 – 133)
32 10 58 (47 – 68) 54 (36 – 73) 112 (92 – 133)
33 11 59 (49 – 70) 53 (35 – 72) 113 (92 – 134)
34 9 61 (50 – 71) 52 (34 – 71) 113 (92 – 134)
35 12 62 (52 – 72) 51 (33 – 69) 113 (92 – 134)
36 10 63 (53 – 74) 50 (31 – 68) 113 (92 – 134)
37 6 65 (54 – 75) 48 (30 – 67) 113 (92 – 134)
38 14 66 (56 – 76) 47 (28 – 65) 112 (91 – 133)
39 9 67 (57 – 78) 45 (26 – 63) 112 (91 – 133)
40 6 69 (58 – 79) 43 (25 – 62) 111 (90 – 132)
41 2 70 (60 – 81) 41 (22 – 60) 110 (89 – 131)
42 1 72 (61 – 82) 39 (20 – 58) 109 (88 – 131)BMC Pregnancy and Childbirth 2004, 4 http://www.biomedcentral.com/1471-2393/4/6
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Table 3: Weekly values for QRS. Estimated value for the QRS complex (all, female and male data) and their respective 90% prediction 
interval (PI) based on the best fitting regression model. Values from the 17th to the 42nd week are given. N is the number of cases 
available for the model in any respective week. p values comparing the female and male QRS durations are given showing the transition 
to statistically distinguishable values at the 31st week (p values < .05 in bold type).
Gestational age 
week
N QRS all (ms) estimated 
value (90% PI)
N QRS female (ms) 
estimated value (90% PI)
N QRS male (ms) 
estimated value (90% PI)
P
17 1 33 (28 – 40) 30 (24 – 37) 1 34 (29 – 41)
18 5 35 (29 – 41) 4 32 (26 – 39) 1 35 (30 – 42)
19 8 36 (30 – 42) 5 34 (28 – 41) 3 37 (31 – 44)
20 9 37 (31 – 44) 5 36 (30 – 42) 4 38 (32 – 45)
21 8 38 (32 – 45) 3 38 (32 – 44) 5 39 (33 – 46)
22 9 39 (33 – 46) 5 39 (33 – 45) 4 40 (34 – 48)
23 13 40 (34 – 47) 7 40 (34 – 46) 6 41 (34 – 49)
24 11 41 (35 – 49) 8 41 (35 – 48) 3 42 (35 – 50)
25 9 42 (36 – 50) 4 43 (36 – 49) 5 43 (36 – 51) 0.576
26 8 43 (37 – 51) 6 44 (37 – 50) 2 44 (37 – 53) 0.537
27 11 44 (37 – 52) 5 44 (38 – 51) 6 45 (38 – 54) 0.467
28 16 45 (38 – 53) 8 45 (39 – 51) 8 46 (39 – 55) 0.335
29 11 46 (39 – 54) 9 46 (40 – 52) 2 47 (40 – 56) 0.211
30 12 47 (40 – 55) 4 47 (41 – 53) 8 48 (40 – 57) 0.100
31 7 48 (41 – 57) 1 48 (41 – 54) 6 49 (41 – 58) 0.034
32 10 49 (41 – 58) 5 48 (42 – 54) 5 50 (42 – 59) 0.009
33 11 50 (42 – 59) 8 49 (43 – 55) 3 51 (43 – 61) 0.001
34 9 51 (43 – 60) 3 49 (43 – 55) 6 52 (43 – 62) <0.001
35 12 52 (44 – 61) 3 50 (44 – 56) 9 53 (44 – 63) <0.001
36 10 52 (44 – 62) 3 50 (44 – 57) 7 54 (45 – 64) <0.001
37 6 53 (45 – 63) 4 51 (45 – 57) 2 54 (46 – 65) <0.001
38 14 54 (46 – 64) 6 51 (45 – 57) 8 55 (46 – 66) <0.001
39 9 55 (47 – 65) 5 52 (46 – 58) 4 56 (47 – 67) <0.001
40 6 56 (47 – 66) 1 52 (46 – 58) 5 57 (48 – 68)
41 2 57 (48 – 67) 1 53 (46 – 59) 1 58 (48 – 69)
42 1 58 (49 – 68) 53 (47 – 59) 1 59 (49 – 70)
Table 4: Values for ST, T and QT. Measures of location for those intervals demonstrating no dependency on gestational age.
N minimum 5th percentile median 95th percentile maximum
ST segment (ms) 217 13 35 72 96 107
T wave (ms) 216 73 96 124 160 180
QT interval (ms) 216 176 192 245 290 306
QTc interval (ms) 216 278 300 380 443 460
Table 5: CTI dependency on biometric data. Dependency of P wave and QRS (determined ≤ 7 days before birth) on birth weight, crown-
heel length and head circumference at birth
N r2 intercept slope p
birth weight (g) P wave 15 0.01 64.6 0.0010 0.768
QRS complex 15 0.08 43.7 0.0029 0.198
crown-heel length (cm) P wave 14 0.06 98.5 -0.589 0.303
QRS complex 14 0.08 27.7 0.490 0.143
head circumference (cm) P wave 14 0.16 10.9 1.63 0.113
QRS complex 14 0.27 -2.0 1.57 0.067BMC Pregnancy and Childbirth 2004, 4 http://www.biomedcentral.com/1471-2393/4/6
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heart has been shown increase over time both with respect
to body weight and gestational age [22] and estimations
of fetal cardiac dimensions and mass based on ultrasound
recording show a steady increase over time [23-25]. The
estimation of these dependencies are, more often than
not, described more adequately using quadratic polyno-
mials than a linear model. This reflects the slowing of the
increase in size with a concomitant higher variance
towards the end of pregnancy. With respect to the change
of QRS duration over time, we found a similar trend in the
data and, consequently, that nonlinear models fitted
more appropriately. This has also been noted by others on
the basis of fetal ECG data [9,26] and further supports the
notion of the link between fetal cardiac dimension and
interval duration.
We compared representative CTI values in the terminal
period of pregnancy, based on our data, to neonatal and
infant PR, QRS and QT times found in the literature
[27,28]. These showed a high degree of agreement for the
duration of AV conduction and ventricular depolariza-
tion. With respect to the T wave, the FMCG measures of
location were lower than those reported for the newborns.
This may be attributed to the rate dependency of the QT
times, as the prepartal heart rate is higher than postpartal.
Another reason for the difference may be the difficulty in
the determination of the FMCG T wave, its low amplitude
waveform shape leading to underestimation of its length.
On the basis of our findings, one further factor leading to
the greater variance of QRS duration towards the end of
pregnancy can be presumed to be fetal gender: a trend to
lower values for females was distinguishable after the 30th
week. Gender based differences in QRS duration have also
been noted by Brambati and Pardi [9], albeit not
statistically significant. Furthermore, in pediatric popula-
tions, QRS duration has been shown to be shorter in girls
than in boys [28,29]. Females are characterized by a lower
birth weight than males, in particularly at later gestational
ages [30]. This trend was also present in our subjects
(males 3716 ± 555 g, females 3438 ± 497 g, p = 0.088). In
the light of the above, the trend to shorter female QRS
duration may correspond at least in part to their lower
body weight. This fact will be of importance, for example,
when investigating the possible association between
growth retardation and CTI [17,20] in order to avoid
masking reduced QRS duration in male subjects.
The results with respect to biometric data were inconclu-
sive: only head circumference displayed a weak relation-
ship to QRS duration. This was surprising, in particular for
birth weight, as such a dependency has been reported in a
larger collective [9]. One of the reasons for the lack of cor-
relation in our data may have been due to the fact that
only 15 FMCG recordings performed within one week of
birth were available for analysis. Furthermore, the rela-
tionships between fetal depolarization times, heart size
and body weight discussed above are largely based on lon-
gitudinal studies. Examining the relationship on a cross
section of subjects within a narrow range of time at the
end of pregnancy when most biometric values are stabiliz-
ing will make the identification of a trend difficult and
will likely require a substantial number of cases. It is how-
ever interesting to note that head circumference, which
showed a weak correlation to QRS, has been identified as
being more reliable than other biometric parameters in
the estimation of fetal age [31,32].
The overall high number of FMCG recordings permitted a
reliable statistical description of the data with respect to
the gestational period observed. However, the results are
limited by the moderate number per week of gestation
(ca. [10]). We did not deem this enough to give a stable
description per week and we preferred instead to extrapo-
late weekly values on the basis of regression analysis
parameters. A higher number of subjects and recordings
would alleviate this limitation. Another aspect which
must be kept in mind is that the precise determination of
gestational age is a prerequisite for the correct estimation
of dependency. We established gestational age as the com-
puted interval between the date of last normal menses and
the date of recording. Although other measures exist [33],
we chose this procedure as it is commonly used and we
did not always have access to ultrasound biometrics or
other documentation.
Conclusions
In summary, we may conclude that fetal CTI which quan-
tify depolarization times can be reliably determined using
FMCG from approximately the 18th week to term, that P
wave and QRS complex duration show a high dependency
on age which to a large part reflects fetal growth and that
fetal gender plays a role in QRS complex duration. Fetal
development is thus reflected in the CTI and may be use-
ful in the identification of pathological states such as
intrauterine growth retardation.
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